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Abstract
The available literature lacks data concerning direct comparison of the effectiveness and safety of single- versus dual-coil implantable
cardioverter-defibrillator (ICD) leads transvenous extraction. Certainly, additional shocking coil in superior vena cava adds to the
amount of metal in the vascular system. Adhesions developing around the superior vena cava coil add to the difficulty of extraction of
ICD lead if lead removal is required. The aim of the study was to assess the effectiveness and safety of single- and dual-coil ICD leads
transvenous extraction usingmechanical systems. We performed transvenous lead extraction (TLE) of 197 ICD leads in 196 patients.
There were 46 (23.3%) dual-coil leads removed from 46 (23.5%) patients. Cardiovascular implantable electronic device-related
infection was an indication for TLE in 25.0% of patients. The following extracting techniques were used: manual direct traction,
mechanical telescopic sheaths, controlled-rotation mechanical sheaths, and femoral approach. Complete ICD lead removal and
complete procedural success in both groups were similar (99.3% in single-coil vs 97.8% in dual-coil, P= .41 and 99.3% in single-coil
vs 97.8% in dual-coil, P=0.41, respectively). We did not find significant difference between major and minor complication rates in
both groups (2.0% in single-coil vs 4.3% in dual-coil, and 0.7% in single-coil vs 0.0% in dual-coil, P= .58, respectively). There was 1
death associated with the TLE procedure of single-coil lead.
This study shows that extraction of dual-coil leads seems to be comparably safe and effective to extraction of single-coil leads. On
the other hand, it requires longer fluoroscopy time and frequent utilization of advanced tools.
Abbreviations: BMI = body mass index, BOB = bridge occlusion balloon, CIED = cardiovascular implantable electronic devices,
CKD-EPI = Chronic Kidney Disease Epidemiology Collaboration, CRP = C reactive protein, CRT-D = cardiac resynchronization
therapy defibrillator, CT = computed tomography, DC = dual-coil, DCL = dual-coil lead, eGRF = estimated glomerular filtration rate,
EHRA = European Heart Rhythm Association, ESC = European Society of Cardiology, HRS = Heart Rhythm Society, ICD =
implantable cardioverter-defibrillator, IVC = inferior vena cava, LDIE = lead-dependent infective endocarditis, LI = local infection,
LVEF = left ventricular ejection fraction, NYHA = New York Heart Association, SC = single-coil, SCL = single-coil lead, SVC =
superior vena cava, TLE = transvenous lead extraction, TOE = transoesophageal echocardiography, TTE = transthoracic
echocardiography.
Keywords: cardiovascular implantable electronic devices, dual-coil lead, effectiveness, implantable cardioverter-defibrillator,
safety, single-coil lead, transvenous lead extraction
1. Introduction
Transvenous lead extraction (TLE) is an integral part of
management of patients with cardiovascular implantable
electronic devices (CIED).[1,2] According to the current guide-
lines, indications for implantable cardioverter-defibrillator (ICD)
therapy have been widened over the last few years.[3,4]
Importantly, ICD leads are prone to damage in long-term
follow-up.[5,6] Kleemann et al demonstrated an increasing annual
rate of failure among ICD leads during long-term follow-up,
which reached 20% in 10-year-old ICD leads.[7] Increasing
number of ICD lead implantations and significant risk of lead
failure have resulted in growing need for TLE procedures
involving ICD leads. Despite the accumulated evidence showing
that single-coil (SC) leads are comparable to dual-coil (DC) leads
in terms of efficacy of defibrillation and overall safety,[8–10] until
recently DC leads have been regarded as the standard of care and
implanted more frequently than SC leads.[10,11]
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The available literature lacks data concerning direct comparison
of both types of ICD leads in termsof extraction efficacy and safety.
The currently available data have demonstrated conflicting results.
Certainly, additional shocking coil in superior vena cava (SVC)
adds to the amount of metal in the vascular system. Adhesions
developing around the SVC coil add to the difficulty of extraction
of ICD lead if lead removal is required.[12,13] Bontempi et al
identified patient and lead characteristics (number of leads,
presence of double coil lead and absence of vegetation) which
influenced the difficulty of TLE procedure.[14] Epstein et al in a
multicenter retrospective study involving 9 high-volume centers
(385 patients with SC and 1791 patients with DC) indicated that
the presence of SVC coil was associated with significantly higher
complication rates. Furthermore, authors observed that the
procedures involving removal of DC ICD leads were about 2.6
timesmore difficult as compared to extraction of SC ICD leads.[12]
Furthermore, Pecha el al in a report on laser ICD lead extraction
concluded that removal of DC ICD leads was associated with
longer laser treatment times but without statistically significant
differences in complication and procedural success rates.[15]
Brunner et al in the group of nearly 3000 TLE procedures with
over5000extracted leadsdidnotfindsignificantly increased riskof
complications related to DC lead removal. Of note, in the
univariate analysis, the DC leads weremore prevalent in the group
of patients in whom complications occurred; however, the
difference was not statistically significant (29.8% vs 43.8%,
P= .086).[16] Additionally, authors of European Lead Extraction
ConTRolled, prospective multicenter European registry of TLE
procedures, did not observe association between DC lead removal
and major cardiac and vascular complications during TLE.[17]
The above-mentioned results and the lack of direct comparison
of extraction of DC and SC leads prompted us to analyze the
outcomes from university reference center for lead extraction.
2. Methods
The aim of the study was to assess the effectiveness and safety of
TLE of SC and DC ICD leads using mechanical systems.
A prospective analysis of the records consisted of all patients
with ICD or cardiac resynchronization therapy defibrillator
(CRT-D), who underwent TLE of SC or DC ICD leads from
October 2011 to December 2018. Patients whose ICD leads had
been implanted for less than 1 year before the procedure were
excluded from the analysis. The population was divided into 2
groups: group single-coil lead (SCL) – during the procedure at
least 1 lead had SC and group dual-coil lead (DCL) – at least 1
lead had DC. Cases with both types of lead targeted for TLEwere
excluded from analysis. Data were collected from the medical
documentation issued at the time of device implant, during
follow-up at outpatient clinics and medical information collected
during TLE procedure and within 30-days post TLE procedure.
The selected groups of patients (SCL and DCL) were compared
by assessing demographic data (age, sex), body mass index
(BMI), the New York Heart Association (NYHA) Functional
Classification and left ventricular ejection fraction (LVEF),
indications for ICD implantation (primary or secondary
prevention), comorbidities including diabetes mellitus and
coronary artery disease, laboratory studies (hemoglobin concen-
tration, creatinine level, estimated glomerular filtration rate
[eGFR]), types of implanted CIED, number of CIED-related
procedures before TLE (implantation, reimplantation, device
upgrade), indications for TLE. Chronic Kidney Disease
Epidemiology Collaboration equation was used to calculate
eGFR. Indications for TLE were divided into 3 categories: lead-
dependent infective endocarditis (LDIE), isolated local infection
(LI) and noninfectious indications. LDIE was diagnosed on the
basis of Modified Duke Leads Criteria, while LI was diagnosed
on the basis of local inflammatory signs which were limited to
device pocket: erythema, excessive warming, fluid in the device
pocket, swelling, leakage of fluid from the device pocket, erosion
of the skin and fistula. When both LDIE and LI were present,
LDIE was used as an indication for TLE.
Lead dislodgement was defined as any lead displacement,
including lead penetration into the myocardium or through the
myocardium into the pericardial cavity – termed cardiac
perforation. Lead dislocation was documented on chest X-ray,
fluoroscopy screening, echocardiography examination, and
cardiac computed tomography (CT) angiogram. Lead perfora-
tion was diagnosed when the lead tip passed through the
myocardium and extended into the pericardial cavity by at least 5
mm with or without pericardial effusion.[6]
In addition, both groups were analyzed and compared in terms
of percentage of passive fixation leads, percentage of nonfunc-
tional/abandoned leads, age of extracted leads, age of the oldest
extracted lead, cumulative age of all extracted leads, number of
extracted leads, fluoroscopy time, techniques used during TLE,
effectiveness of TLE, complete/incomplete lead removal for each
lead removed, complications occurring during intraoperative,
and 30-day postoperative period.
The effectiveness of TLE procedures was divided into 3
categories according to current Heart Rhythm Society (HRS) and
European Heart Rhythm Association (EHRA) consensus[1,2,18]:
 complete procedural success: removal of all targeted leads and all
lead material from the vascular space, with the absence of any
permanently disabling complication or procedure-related death;
 clinical success: removal of all targeted leads and lead material
from the vascular space, or retention of a small portion of the
lead, which does not negatively impact the outcome goals of
the procedure. This may be the tip of the lead or a small part of
the lead (conductor coil, insulation, or the latter 2 combined)
when the residual part does not increase the risk of perforation,
embolic events, perpetuation of infection, or cause any
undesired outcome;
 failure of the procedure: inability to achieve either complete
procedural or clinical success, or the development of any
permanently disabling complication or procedure-related death.
For each electrode removed, the efficiency according to the
EHRA consensus was determined[18]:
 complete lead removal – lead explant or extraction with
removal of all targeted lead material,
 incomplete lead removal – lead explant or extraction where
part of the lead remains in the patient’s body (vascular or
extravascular).
We recorded complications occurring in intraoperative and 30-
day postoperative period and classified as 2 types in accordance
with HRS and EHRA consensus[1,2,18]:
 major complication: any of the outcomes related to the
procedure which is life threatening or results in death. In
addition, any unexpected event that causes persistent or
significant disability, or any event that requires significant
surgical intervention to prevent any of outcomes listed above;
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 minor complication: any undesired event related to the
procedure that requires medical intervention or minor
procedural intervention to remedy the complications, and
does not limit persistently or significantly the patient’s function,
nor does it threaten life or cause death.
The institutional ethics committee approved the study
protocol, and written informed consent was obtained from all
patients for the use of their anonymous data in the present
publication. The study protocol conformed to the ethical
guidelines of the 1975 Declaration of Helsinki.
The study complied with the principles of the Good Clinical
Practice guidelines and was approved by the Jagiellonian
University Ethics Committee – No: KBET/259/B/2011.
2.1. TLE procedure
The description of TLE procedure has been presented previous-
ly.[19] The patient preparation for TLE procedure consisted of the
following tests: laboratory tests, chest X-ray, TTE in all patients,
transoesophageal echocardiography (TOE) in majority of
patients, preoperative device assessment, and evaluation of
pacemaker dependency. Before the operation ipsilateral venog-
raphy was performed in patients without contraindications to
contrast medium. In noninfectious patients the antibiotic
prophylaxis was routinely administered, whereas in infectious
cases the antimicrobial therapy was continued.
All the procedures were performed in hybrid operating room
with on-site cardiothoracic surgical standby, under general
anesthesia or intravenous sedation. During the procedure
continuous invasive monitoring of blood pressure, blood
saturation and electrocardiogram was used. Most of the patients
were additionally monitored with TOE. In pacemaker-dependent
patients a temporary pacing wire was inserted from the femoral
vein. The primary access site used by the operators was the
implant vein. While extracting the lead we used a stepwise
approach. Simple traction was the first extraction technique used
in active fixation and relatively young leads. At the next step we
utilized nonpowered extraction tools. Standard stylets were used
to stiffen the leads. If the lumen of the lead allowed the insertion
of the stylet to its tip, the locking stylets (Liberator Beacon Tip
Locking Stylet, Cook Medical or Lead Locking Device,
Spectranetics) were used from December 2013. We utilized
telescoping dilators (Cook Medical, Bloomington, IN). Powered
extraction tools (cutting sheath system – Evolution, Cook
Medical) were usually applied when previously used nonpowered
extraction tools failed. In case of leads which were completely in
the cardiovascular system either before the procedure or as a
result of lead fracture during the procedure, the femoral approach
was utilized. Laser techniques and electrosurgical sheaths were
not used. Pacemaker-dependent patients who underwent TLE
due to infectious indications were bridged to reimplantation with
a temporary active-fixation lead implanted on the ipsilateral side
of the chest and connected to the externalized permanent
pacemaker generator.[20] Furthermore, in patients at a very high
risk of sudden cardiac death we implanted a temporary external
ICD as a bridge to ICD reimplantation.[21]
2.2. Statistical analysis
The analysis was performed using StatSoft Statistica version 13.1
(StatSoft, Tulsa, OK). Continuous variables were expressed as
mean± standard deviation and additionally as median and
interquartile range. Shapiro–Wilk W test was used to assess
the normality of continuous variables. Comparisons of 2 groups
of categorical variables were performed with Student t tests of
unpaired samples, and in cases of non-normality or small sample
sizes, the Mann–Whitney U test was used. The categorical
variables were presented as the number of observations in each
category and the percentage of observations in that category.
Categorical variables were compared with Chi-square tests. The
2 2 contingency tables were analyzed using the Chi-square test,
Chi-square test with Yates continuity correction, or Fisher exact
test.
All statistical tests were 2-tailed and a P-value <.05 was
considered statistically significant.
3. Results
The study population consisted of 196 patients at the age of 62.7
±14.3 (range, 22.5–87.6) years, 44 (22.4%) were female. One
patient was excluded in whom due to infective complications
(LDIE) an active DC lead and a nonfunctional SC were extracted.
The leads were extracted due to various indications (29 pts due to
LDIE, 20 pts due to LI, 147 patients due to noninfectious
indications). In analyzed group there were 150 patients with ICD
and 46 with CRT-D. In total 311 leads were extracted with lead
dwell time of 5.5±3.6 years. There were 197 ICD leads with
dwell time of 5.6±3.5 years. Clinical characteristics of patients in
SCL and DCL groups were presented in Table 1. Both groups
were similar in terms of age at the extraction, percentage of
women, ratio of secondary to primary prevention of sudden
cardiac death indication, type of the device, the rate of infectious
indications, incidence of diabetes mellitus, coronary artery
disease, peripheral artery disease, dyslipidemia, hypertension,
atrial fibrillation, and chronic obstructive pulmonary disease.
Moreover, both groups had comparable LVEF and percentage of
patients in NYHA class III and IV. Additionally, creatinine level,
C-reactive protein, eGFR, hemoglobin and BMI index were
similarly distributed (Table 1).
Patients with DC ICD leads had significantly more previous
device-related interventions compared with patients with SC ICD
leads (1.9 vs 1.6, P= .03).
Comparison of extracted leads and results of TLE procedures
in both groups were presented in Table 2. We extracted 151 ICD
leads in SCL group and 46 ICD leads in DCL group. Concerning
other types of leads, in SCL group there were 82 pacing leads
removed including 14 left ventricular leads, whereas in DCL
group there were 32 pacing leads removed including 6 left
ventricular leads. The mean dwell time of all extracted leads,
mean dwell time of only ICD leads, age of the oldest extracted
lead and sum of the dwell time of all extracted leads were
significantly higher in DCL group compared to SCL group
(P< .001). In SCL group there were significantly less leads with
passive fixation compared to DCL group (9.3% vs 26.1%,
P< .01). In both groups the percentage of abandoned leads and
the percentage of patients in whom 3 or more leads were removed
were similar – Table 2. We observed comparable number of
extracted leads per procedure (1.6 vs 1.7, P= .27) and complete
procedural success (99.1% vs 98.7%, P> .99) in both groups.
Considering only ICD leads, the extraction efficacy was still not
significantly different (99.3% vs 97.8%, P=0.41).
Incomplete ICD lead removal occurred in 1 lead in each group.
In SCL group over 13% of ICD leads were removed with simple
traction, on contrary to DCL group in which 2 (4.4%) leads were
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extracted with that method (4.4%). Extraction of leads in DCL
group required more often use of evolution mechanical system.
Femoral access was not performed in DCL group in contrast to
SCL group. Fluoroscopic screening time during DC leads
extraction was significantly longer than in SCL group (3.9
minutes vs 2.0minutes, P< .01).
The effectiveness of TLE in present cohort was high and
comparable in both groups (P= .41). Complete procedural
success was achieved in 194 pts (99.0%), and failure in 2 pts
(1.0%). Among patients with SC ICD leads complete procedural
success was achieved in 99.3% of patients. Failure occurred in 1
patient as an intraoperative death. In DCL group occurred 1
procedural failure – during extraction of nearly 13-year-old
dysfunctional DC ICD passive-fixation lead its distal coil
remained in myocardium in spite of performing various retrieval
techniques. In the whole study population there was 1 (0.5%)
minor complication and 5 (2.6%) major complications.
All targeted leads in group DCL required more advanced
extraction tools compared to leads in SCL group (P< .01).
Similar result was noted for comparison of only ICD leads
(P= .02) – Table 2. In the SCL group, statistically significantly
more leads were removed with a simple traction. The success rate
of simple traction technique was higher in patients with a device-
related infection. Infectious indications were present in 25% of
study population. A total of 54 pacing and SC ICD leads were
extracted with a simple traction: 23 (42.6%) leads of the infected
devices (LDIE and LI) and 31 leads in patients with non-
infectious indications (P= .02). That association was no longer
significant when only ICD leads were analyzed. Of 21 SC ICD
leads removed with a simple traction, 8 (38.1%) were extracted
due to device infection (P= .30).
The safety in both groups was comparable – Table 2. In SCL
group 3 major complications were identified (intraoperative
death, hemorrhage to pleural cavity requiring drainage
and cardiac tamponade managed surgically) and 1 minor
complication (pneumothorax). Intraoperative death in a
patient in SCL group occurred in a 70-year-old woman with
a single-chamber ICD who was referred for TLE due to 3.6-
year-old SC ICD lead dysfunction and total occlusion of
ipsilateral venous access. An upgrade to CRT-Dwas planned as
she presented with heart failure in NYHA class III and LVEF of
less than 15%. Leadwas extracted with green telescopic sheath,
Cook Medical (inner diameter of the innermost sheath – 10 Fr)
from ipsilateral subclavian vein access. A massive hemorrhage
from SVC occurred as a result of vessel injury caused by
telescopic sheaths. Despite an immediate intervention of a
cardiothoracic surgeon the patient died during the procedure.
The Bridge Occlusion Balloon (BOB) (Bridge; Spectranetics
Corporation, Colorado Springs, CO) was not used as it was
unavailable on the market at the time. Hemorrhage to the
pleural cavity requiring drainage occurred during extraction of
7.1-year-old dysfunctional SC ICD lead in a 26-year-old patient
with a dual-chamber ICD and with a history of surgical
correction of Tetralogy of Fallot. Ipsilateral venography
showed subclavian vein patency and the presence of a loop
created by ICD lead inside subclavian vein. During the
extraction of ICD lead with green dilator sheath the left
subclavian vein and left pleura were damaged.[22]
Table 1
Clinical characteristics of patients and type of implanted devices and leads in both groups of patients.
Parameter All patients (n=196) SCL group (n=150) DCL group (n=46) P value
Age of pts, yr [mean±SD; Me; IQR] 62.7±14.3; 63.9; 18.8 62.5±14.8; 64.5; 20.7 63.4±12.7; 62.9; 14.9 P= .97
Female, n (%) 44 (22.4) 37 (24.7) 7 (15.2) P= .18
LVEF, (%) [mean±SD; Me; IQR] 34.6±14.8; 30.0; 22.5 34.8±15.1; 30.0; 23.0 34.0±13.9; 31.0; 22.0 P= .91
NYHA class III or IV, n (%) 79 (40.3) 60 (40.0) 19 (41.3) P= .87
Secondary prevention, n (%) 83 (42.3) 60 (40.0) 23 (50.0) P= .23
BMI, kg/m2 [mean±SD; Me; IQR] 27.9±6.8; 27.3; 6.6 27.6±7.1; 27.1; 6.3 28.7±5.9; 28.0; 6.8 P= .16
Hb, g/dL [mean±SD; Me; IQR] 13.7±1.9; 14.0; 2.4 13.6±1.9; 13.9; 2.5 14.0±1.6; 14.1; 2.9 P= .31
CRP, mg/L [mean±SD; Me; IQR] 19.8±52.8; 2.7; 7.5 20.3±56.3; 2.7; 7.0 18.4±39.8; 2.5; 9.0 P= .90
Creatinine, umol/L [mean±SD; Me; IQR] 106.7±53.8; 97.0; 40.0 107.8±58.8; 96.0; 40.0 102.8±33.0; 100.0; 38.0 P= .64
eGFR, mL/min/1.73 m2 [mean±SD; Me; IQR] 69.1±25.4; 71.1; 39.0 69.1±26.1; 72.0; 42.0 69.1±23.3; 62.7; 35.0 P= .96
Diabetes mellitus, n (%) 66 (33.7) 50 (33.3) 16 (34.8) P= .87
Coronary artery disease, n (%) 129 (65.8) 100 (66.7) 29 (63.0) P= .65
Peripheral artery disease, n (%) 116 (59.2) 90 (60.0) 26 (56.5) P= .67
Dyslipidemia, n (%) 158 (80.6) 121 (80.7) 37 (80.4) P= .97
Hypertension, n (%) 122 (62.4) 91 (60.7) 31 (67.4) P= .41
Atrial fibrillation, n (%) 83 (42.3) 58 (38.7) 24 (54.3) P= .10
Chronic obstructive pulmonary disease, n (%) 24 (12.2) 21 (14.0) 3 (6.5) P= .27
Implanted device
ICD, n (%) 150 (76.5) 113 (75.3) 37 (80.4) P= .47
CRT-D, n (%) 46 (23.5)
∗
37 (24.7)
∗
9 (19.6)
Indications for TLE
LDIE, n (%) 29 (14.8) 22 (14.7) 7 (15.2) P= .98
LI, n (%) 20 (10.2) 15 (10.0) 5 (10.9)
Noninfectious indications, n (%) 147 (75.0) 113 (75.3) 34 (73.9)
Number of previously performed procedures, 1 [mean±SD; Me; IQR] 1.7±0.9; 1.0; 1.0 1.6±0.9; 1.0; 1.0 1.9±0.7; 2.0; 1.0 P= .03
BMI=body mass index, CRP=C-reactive protein, CRT-D= cardiac resynchronization therapy defibrillator, DCL=dual-coil lead, eGFR= estimated glomerular filtration rate, Hb=hemoglobin, ICD= implantable
cardioverter-defibrillator, LDIE= lead-dependent infective endocarditis, LI= local infection, LVEF= left ventricular ejection fraction, NYHA=New York Heart Association, SCL= single-coil lead, TLE= transvenous
lead extraction.
∗
In 1 patient – the lack of pacing system, remaining fragment of ICD lead after heart transplant.
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Cardiac tamponade requiring surgical intervention occurred in
a 41-year-old woman with hypertrophic cardiomyopathy and a
dual-chamber ICD in a secondary prevention of sudden cardiac
death. The indication for an extraction was SC ICD lead
dysfunction of 11.7-year-old lead. Green, white, and orange
telescopic sheaths (inner diameter of the innermost sheaths – 10
Fr, 11.5 Fr, and 13 Fr) were used to extract ICD lead.
In DCL group there were 2 major complications (cardiac
tamponades requiring surgical intervention). During extraction
of DC ICD leads with telescopic sheaths the free wall of the right
ventricle was damaged and caused tamponade. Both complica-
tions were caused by a lead tip penetration into the myocardium
without lead perforation in TTE and cardiac CT angiogram.
Additional information on major complication in both groups
was presented in Table 3.
We observed a trend towards more frequent occurrence of
major complications in DCL group (4.3% vs 2.0%, P= .58);
however, the difference was not statistically significant.
Total mortality within 30-day period was 3.6% (7 patients)
and there was no significant difference between groups (2.7% in
SCL group vs 6.5% in DCL group, P= .36) – Table 2. Among
patients who died, 4 had LDIE (1 in SCL group and 3 in DCL
group; all died due to severe heart failure or sepsis). The
remainder were in SC group and were referred to TLE due to
noninfectious indications (1 patient died during TLE procedure
and 2 died due to thromboembolic events).
4. Discussion
In our study cohort noninfectious indications were present in
75% of patients. The observed low rate of TLE due to infection is
consistent with our strategy to rigorously treat pacing-related
complications and has been shown in our previous
reports.[6,19,23] The qualification for TLE procedure was based
on careful consideration involving patient whether to abandon or
remove a lead and/or CIED.[6] This process has been in line with
Table 2
Comparison of extracted leads and results of TLE procedures in both groups.
Parameter All patients (n=196) SCL group (n=150) DCL group (n=46) P value
No of all extracted leads 311 233 78 –
No of extracted ICD leads 197 151 46 –
Passive fixation of ICD leads, n (%) 26 (13.2) 14 (9.3) 12 (26.1) P< .01
Age of extracted lead, yr [mean±SD; Me; IQR]
∗
5.5±3.6; 4.9; 4.5 5.1±3.6; 4.5; 4.1 6.9±3.5; 7.0; 4.4 P< .001
Age of extracted ICD lead, yr [mean±SD; Me; IQR]† 5.6±3.5; 5.1; 4.1 5.1±3.4; 4.6; 3.8 7.1±3.5; 7.0; 4.4 P< .001
Oldest extracted lead, yr [mean±SD; Me; IQR]
∗
5.9±3.8; 5.2; 4.3 5.4±3.8; 4.7; 3.8 7.6±3.6; 7.5; 4.9 P< .001
Sum of age of extracted leads, yr [mean±SD; Me; IQR]
∗
8.8±6.5; 7.0; 8.0 7.9±6.2; 6.4; 6.7 11.7±6.9; 9.9; 10.3 P< .001
Patients with 1 abandoned lead, n (%) 5 (2.6) 4 (2.7)
∗
1 (2.2) P= .73
Patients with 2 or more abandoned leads, n (%) 0 (0.0)
∗
0 (0.0)
∗
0 (0.0)
∗
P> .99
Patients with 3 or more extracted leads, n (%) 21 (10.7) 15 (10.0) 6 (13.0) P= .76
Extracted leads per procedure, 1 [mean±SD; Me; IQR] 1.6±0.7; 1.0; 1.0 1.6±0.7; 1.0; 1.0 1.7±0.8 2.0; 1.0 P= .27
Leads:
Complete lead removal (all leads), n (%) 308 (99.0) 231 (99.1) 77 (98.7) P> .99
Incomplete lead removal (all leads), n (%) 3 (1.0) 2 (0.9) 1 (1.3)
Complete lead removal (ICD leads), n (%) 195 (99.0) 150 (99.3) 45 (97.8) P= .41
Incomplete lead removal (ICD leads), n (%) 2 (1.0) 1 (0.7) 1 (2.2)
Finally effective techniques:
Simple traction, n (%) 61 (19.6) 54 (23.2) 7 (9.0) P< .01
Telescopic sheaths, n (%) 236 (75.9) 168 (72.1) 68 (87.2)
Evolution mechanical system, n (%) 5 (1.6) 2 (0.9) 3 (3.8)
Femoral access, n (%) 9 (2.9) 9 (3.8) 0 (0.0)
Simple traction (only ICD leads), n (%) 23 (11.7) 21 (13.9) 2 (4.4) P= .02
Telescopic sheaths (only ICD leads), n (%) 161 (81.7) 120 (79.5) 41 (89.1)
Evolution mechanical system (only ICD leads), n (%) 5 (2.5) 2 (1.3) 3 (6.5)
Femoral access (only ICD leads), n (%) 8 (4.1) 8 (5.3) 0 (0.0)
Fluoroscopy time during ICD lead removal, min [mean±SD; Me; IQR] 2.5±4.2; 1.3; 1.7 2.0±2.4; 1.2; 1.8 3.9±7.5; 1.5; 2.3 P< .01
Total fluoroscopy time during all leads removal, min [mean±SD; Me; IQR] 3.4±5.3; 1.9; 3.0 2.8±3.4; 1.8; 2.7 5.2±8.9; 2.3; 2.9 P= .02
Procedures:
Complete success, n (%) 194 (99.0) 149 (99.3) 45 (97.8) P= .41
Clinical success, n (%) 0 (0.0) 0 (0.0) 0 (0.0)
Failure, n (%) 2 (1.0) 1 (0.7) 1 (2.2)
Complications:
No complications, n (%) 190 (96.9) 146 (97.3) 44 (95.7) P= .58
Minor complications, n (%) 1 (0.5) 1 (0.7) 0 (0.0)
Major complications, n (%) 5 (2.6) 3 (2.0) 2 (4.3)
Deaths:
Intraoperative period procedure-related, n (%) 1 (0.5) 1 (0.7) 0 (0.0) P> .99
During 30-d postoperative period procedure-related, n (%) 7 (3.6) 4 (2.7) 3 (6.5) P=0.36
DCL=dual-coil lead, ICD= implantable cardioverter-defibrillator, SCL= single-coil lead.
∗
Including all leads: pacing and ICD leads.
† Only ICD leads.
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the current expert consensus statement.[2] The tendency towards
higher frequency of noninfectious indications for TLE has been
noted previously in other centers in Poland.[24] In present
population SC ICD leads were in the majority of extracted leads
(76.6%). It is in contrast to previous studies in which DC ICD
leads were usually in the majority.[8,12,16,25] In our cohort
prevailed SC leads which are currently considered as the leads of
first choice for routine new left-sided ICD implants. However,
DC ICD leads were implanted more frequently in the initial
period of ICD implantations which is showing gradual move
towards SC ICD leads. This observation is in accordance with the
results from meta-analysis including 18 studies.[26] Noteworthy,
data from ALTITUDE Study demonstrated that SC lead
implantations increased from 1.9% to 55.2% between 2004
and 2014.[27] Moreover, in Israeli ICD Database, a prospective
registry of all patients referred for implantation or replacement of
ICD or CRT-D for primary and secondary prevention, percent-
age of DC ICD leads implantations has been gradually
decreasing.[11] In our cohort DC ICD leads were more frequently
with passive fixation and had long dwell-time which may be
explained by an earlier time of implantation of these ICD systems.
Furthermore, this observation is supported by a higher number of
prior device-related interventions in DCL group (mostly ICD
generator change) compared to SCL group (1.9 vs 1.6, P= .03).
Older age of ICD leads and higher percentage of passive fixation
leads contributed to longer fluoroscopic screening time during
extraction of DC leads compared to SC leads (3.9minutes vs 2.0
minutes, P=0.021). Similar results have been obtained by other
researchers. Pecha el al showed that extraction of DC ICD leads
was associated with longer laser treatment times.[15] Additional-
ly, Bontempi et al demonstrated that among nonindependent
factors increasing the fluoroscopy time was a presence of DC
lead.[14]
Present study showed that the extraction of DC ICD leads
required more frequent use of mechanical systems compared to
simple traction. Similar conclusions were drawn by Bongiorni
et al who observed that longer lead dwell time, passive fixation,
and DC construction predicted a more challenging extraction
procedure.[28] The association between the presence of DC ICD
lead and the difficulty of extraction has been mentioned in other
reports.[12,13] Pacing and ICD leads were more frequently
removed with a simple traction in SCL group compared to
DCL group which may be explained by the lack of additional coil
in SVC; however, longer dwell time of leads in DCL leads might
need to be factored in as well. Authors observed a trend toward
higher success rate of simple traction in SCL group in infectious
indications. In our study population the infectious indications
were in the minority; therefore, that association might be
incidental. Consequently, it warrants further research as the
evidence in the current literature is insufficient.
Major perioperative complication rate in our study was 2.6%.
In a recently published registry of 11,304 TLE procedures (8632
high-voltage lead extraction and 2942 pacing lead extraction
procedures) performed in 762 centers, authors reported 2.4%
incidence of major perioperative complications during ICD lead
extraction,[25] which is comparable to our outcomes. One
intraprocedural death occurred as a result of SVC injury caused
by telescopic sheaths. Injury to the SVC, though uncommon, is a
serious and potentially fatal complication of TLE and occurs in
approximately 0.5% of procedures.[29] The BOB can enable
hemodynamic stability through control of hemorrhage by
occluding the SVC in the minutes required for full open access
to the chest.[30] According to Brunner et al, situations that may be
considered higher risk and warrant staging BOB on the wire and
placement in the inferior vena cava (IVC) may include the
following: female patients, low BMI (<25kg/m2), low LVEF,
ICD leads, DC ICD leads, multiple indwelling leads (≥4),
combined age of leads over 10 (sum of every implanted lead
multiplied by its implant duration), difficult case with multiple
extraction tools already used, after familiarity or competency
practice placement.[30] In our opinion, we would have considered
staging BOB on the wire and placement in the IVC in such a case.
In present study the effectiveness and safety of TLE extraction
of DC and SC leads were comparable; however, there was a trend
towards more frequent complications in patients with DC leads
(4.3% vs 2.0%, P= .58). It concurs with the previous report by
Brunner et al.[16]
Epstein et al noted a higher rate of TLE complications in 1791
patients with DC leads compared to 385 patients with SC ICD
leads.[12] Importantly, in the report by Epstein et al DC leads had
much shorter mean dwell time compared to our group of DC
leads (38.2 months vs 85.2 months).
Sood et al did not find association between DC ICD lead
construction and the risk of major TLE complication; however,
did find a 4% increased relative risk ofmajor complication per 10
mm2 increase in proximal surface coil area.[25] Authors thought
this was as a surrogate marker of increased risk for perioperative
complications associated with DC leads.
The increased risk of TLE in the group of DC ICD leads might
have been caused by a longer dwelling time of those leads. Brunner
Table 3
Major complications in both groups.
ICD
lead
type Gender
Age,
yr
Left ventricular
ejection
fraction (%)
BMI,
kg/m2
Implanted
device
Prevention
of sudden
cardiac death
Age of
extracted
ICD lead, yr
ICD
lead
fixation
Fluoroscopy time
during ICD lead
extraction, min
Utilized tools (maximum
inner diameter of the
innermost sheath), Fr Complication
SCL F 70 15 22.1 ICD-VR Secondary 3.6 Active 2.67 Telescopic sheath (10) Intraoperative death
secondary to superior
vena cava tear
SCL M 26 60 22.0 ICD-DR Secondary 7.1 Passive 0.67 Telescopic sheath (10) Haemorrhage to pleural cavity
SCL F 41 58 29.7 ICD-DR Secondary 11.7 Passive 2.67 Telescopic sheath (13) Cardiac tamponade
DCL M 46 50 27.1 ICD-VR Secondary 2.9 Active 0.67 Telescopic sheath (13) Cardiac tamponade
DCL M 58 30 30.4 ICD-VR Primary 4.5 Active 3.00 Telescopic sheath (13.0) Cardiac tamponade
BMI=body mass index, DCL=dual-coil lead, F= female, ICD= implantable cardioverter-defibrillator, ICD-DR=dual-chamber implantable cardioverter-defibrillator, ICD-VR= single-chamber implantable
cardioverter-defibrillator, M=male, SCL= single coil lead.
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et al in the group of nearly 3000 TLE procedures and over 5000
extracted leads considered in univariate analysis the presence of
DC ICD lead as a risk factor for major complications, major
cardiovascular injury and all-cause mortality within 30 days of
TLE. However, in a multivariate analysis this parameter was no
longer associated with increased risk of complications or all-cause
mortality within 30 days of TLE, whereas the cumulative age of all
leads extracted affected significantly those outcomes.[16]
All-cause mortality in our patients within 30 days of TLE was
3.6% (2.7% in SCL group and 6.5% in DC L group, P= .36).
Noteworthy, we observed a trend towards higher mortality
within 30 days of TLE among patients with DC ICD leads. Other
authors also noted higher mortality rate in patients with DC ICD
leads within 30 days after extraction.[31] Literature has not
provided a conclusive explanation of this phenomenon to date.
We have assumed that tendency towards higher mortality rate in
patients with DC ICD leads within 30 days following TLE might
have been related to the complications of LDIE.
Consistently with the report by Sunderland el al. we showed
that given the increased risk and complexity of extracting DC
ICD leads, centers should strongly consider SC leads as the lead of
the first choice for routine new left-sided ICD implants.[26]
4.1. Study limitations
Themain study limitationwas a relatively small sample of patients
with DC ICD leads and single-center experience. No comparison
wasmade betweenmechanical dilator sheaths or Evolution system
and other techniques currently used for TLE because the authors
used only themechanical systems. Furthermore, the follow-upwas
limited to 30-day post-procedural period. This study presents
outcomes of high volume center and operators with expertise in
mechanical extraction systems and; therefore, our results may not
be widely applicable to less experienced centers.
4.2. Future directions
Further research involving more patients is needed. Moreover,
outcomes beyond 30-day post TLE are warranted. Finally, other
extraction techniques, that is, laser could be explored in terms of
efficacy and safety and compared to mechanical techniques.
5. Conclusions
The TLE procedures involving extraction of SC and DC ICD
leads were effective and safe. The outcomes of DC ICD leads
removal did not differ significantly compared to SC ICD leads,
although extraction of DC ICD leads required more advanced
tools and longer fluoroscopy time.
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[21] Dębski M, Ząbek A, Boczar K, et al. Temporary external implantable
cardioverter-defibrillator as a bridge to reimplantation after infected
device extraction. J Arrhythm 2018;34:77–80.
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